Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Loss of function of FAM177A1, a Golgi complex localized protein, causes a novel neurodevelopmental disorder

ABSTRACT: Loss of function of FAM177A1, a Golgi complex localized protein, causes a novel neurodevelopmental disorder

PROVIDER: PRJNA1044115 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR26923905_1.fastq.gz	Fastqsanger.gz
	SRR26923905_2.fastq.gz	Fastqsanger.gz
	SRR26923906_1.fastq.gz	Fastqsanger.gz
	SRR26923906_2.fastq.gz	Fastqsanger.gz
	SRR26923907_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 18

Similar Datasets

Loss of function of FAM177A1, a Golgi complex localized protein, causes a novel neurodevelopmental disorder

Project description:Purpose The function of FAM177A1 and its relationship to human disease is largely unknown. Recent studies have demonstrated FAM177A1 to be a critical immune-associated gene. One previous case study has linked FAM177A1 to a neurodevelopmental disorder in four siblings. Methods We identified five individuals from three unrelated families with biallelic variants in FAM177A1. The physiological function of FAM177A1 was studied in a zebrafish model organism and human cell lines with loss-of-function variants similar to the affected cohort. Results These individuals share a characteristic phenotype defined by macrocephaly, global developmental delay, intellectual disability, seizures, behavioral abnormalities, hypotonia, and gait disturbance. We show that FAM177A1 localizes to the Golgi complex in mammalian and zebrafish cells. Intersection of the RNA-seq and metabolomic datasets from FAM177A1-deficient human fibroblasts and whole zebrafish larvae demonstrated misregulation of pathways associated with apoptosis, inflammation, and negative regulation of cell proliferation. Conclusion Our data sheds light on the emerging function of FAM177A1 and defines FAM177A1-related neurodevelopmental disorder as a new clinical entity.

2023-11-22 | GSE248488 | GEO

Epigenome analysis of control and neurodevelopmental disorder lymphoblastoid cell lines

Project description:Genome wide DNA methylation profiling of control and neurodevelopmental disorder lymphoblastoid cell lines (LCL). The Illumina Infinium 27k Human DNA methylation Beadchip v1.2 was used to obtain DNA methylation profiles across approximately 27,000 CpGs in LCLs. Samples included 19 control, 18 Rett syndrome, 17 autism and 6 generalized epilepsy LCL samples. Six technical replicates were also included in the analysis. Bisulphite converted DNA from the 60 samples and 5 technical replicates were hybridised to the Illumina Infinium 27k Human Methylation Beadchip v1.2

2012-12-01 | E-GEOD-34099 | biostudies-arrayexpress

Spliceosome malfunction causes neurodevelopmental disorders with overlapping features

Project description:Spliceosome malfunction causes neurodevelopmental disorders with overlapping features

| PRJNA1031622 | ENA

Transcriptome analysis of the Golgi stress response

Project description:We explore the transcriptional response of mammalian cells undergoing various insults to Golgi homeostasis. HEK293 cells (Flp-In T-REx 293 cells) stably containing a doxycycline-inducible Golgi-localized HaloTag2 construct (GA-HT2) were treated with the ionophore nigericin, the glycosylation inhibitor xyloside, or were induced by doxycycline and treated with the hydrophobic tag HyT36 to induce destabilization of GA-HT2. We found that while nigericin and xyloside induce global transcriptional changes, destabilization of GA-HT2 induces a Golgi-specific response.

2018-06-21 | GSE99490 | GEO

Spliceosome malfunction causes neurodevelopmental disorders with overlapping features (human)

Project description:Spliceosome malfunction causes neurodevelopmental disorders with overlapping features (human)

| PRJNA1031628 | ENA

FUS-NLS mutation causes neurodevelopmental and systemic metabolic alterations

Project description:FUS-NLS mutation causes neurodevelopmental and systemic metabolic alterations

| PRJNA1028651 | ENA

Spliceosome malfunction causes neurodevelopmental disorders with overlapping features (fly)

Project description:Spliceosome malfunction causes neurodevelopmental disorders with overlapping features (fly)

| PRJNA1031629 | ENA

Epigenome analysis of control and neurodevelopmental disorder lymphoblastoid cell lines

2012-12-01 | GSE34099 | GEO

Impaired glycosylation drives golgi stress-mediated gastric tumorigenesis that can be targeted by lectin-drug conjugates

Project description:Downregulation or gene mutation of MUC6, a major component of gastric mucin, is often identified in human gastric cancers. However, the mechanistic role of MUC6 alteration in gastric carcinogenesis remains unclear. Here, using Muc6-deficient mice, we revealed that dysregulated glycosylation in Muc6-deficient gastric epithelium causes aberrant golgi stress responses, resulting in spontaneous gastric cancer development. Muc6-deficient tumor growth is dependent on MAPK activation, which is mediated by golgi stress-induced golph3 upregulation. Glycomic analysis and lectin-binding assays revealed abnormal expression of mannose-rich N-type glycans in Muc6-deficient gastric tumors. Banana lectin-drug conjugates, which bind to mannose-rich glycans, dramatically suppress mannose-rich murine and human gastric cancer growth. Thus, we propose golgi stress responses and aberrant sugar chains as promising therapeutic targets in gastric cancers accompanied with mucin expression disorder.

2024-08-31 | GSE237822 | GEO

Impaired glycosylation drives golgi stress-mediated gastric tumorigenesis that can be targeted by lectin-drug conjugates

2024-08-31 | GSE237686 | GEO